Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2023; 13(1):16-19. doi:10.7150/thno.79085 This issue Cite

Erratum

Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: Erratum

Xun Sun1,2, Kexin Li1,2, Misato Hase2,3, Rongrong Zha1,2, Yan Feng1,2, Bai-Yan Li1✉, Hiroki Yokota1,2,4,5✉

1. Department of Pharmacology, School of Pharmacy, Harbin Medical University, Harbin 150081, China
2. Department of Biomedical Engineering, Indiana University Purdue University Indianapolis, Indianapolis, IN 46202, USA
3. Graduate School of Engineering, Mie University, Mie 514, Japan
4. Indiana Center for Musculoskeletal Health, Indiana University School of Medicine, Indianapolis, IN 46202, USA
5. Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA

✉ Corresponding authors: Bai-Yan Li and Hiroki Yokota.

Citation:
Sun X, Li K, Hase M, Zha R, Feng Y, Li BY, Yokota H. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: Erratum. Theranostics 2023; 13(1):16-19. doi:10.7150/thno.79085. https://www.thno.org/v13p0016.htm
Other styles

File import instruction

Corrected-article in Theranostics, Volume 12, 929

Citation styles

APA
Sun, X., Li, K., Hase, M., Zha, R., Feng, Y., Li, B.Y., Yokota, H. (2023). Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: Erratum. Theranostics, 13(1), 16-19. https://doi.org/10.7150/thno.79085.

ACS
Sun, X.; Li, K.; Hase, M.; Zha, R.; Feng, Y.; Li, B.Y.; Yokota, H. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: Erratum. Theranostics 2023, 13 (1), 16-19. DOI: 10.7150/thno.79085.

NLM
Sun X, Li K, Hase M, Zha R, Feng Y, Li BY, Yokota H. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: Erratum. Theranostics 2023; 13(1):16-19. doi:10.7150/thno.79085. https://www.thno.org/v13p0016.htm

CSE
Sun X, Li K, Hase M, Zha R, Feng Y, Li BY, Yokota H. 2023. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: Erratum. Theranostics. 13(1):16-19.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use